Please assess the completion status of the following clinical trial:

Trial Title: Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Men or women ≥18 to \<80 years of age who present with any one of the following:~* symptoms of Acute Coronary Syndromes (ACS)~* clinical symptoms of angina, or a positive stress test or who return for routine follow up angiography post stent placement in whom co-administration of aspirin and a thienopyridine (that is, clopidogrel, ticlopidine, or prasugrel) is not contraindicated~Exclusion Criteria:~* Those presenting with ST-elevation MI (STEMI)~* histories of refractory ventricular arrhythmias~* an implanted defibrillator device~* congestive heart failure (NYHA Class III or above) within 6 months prior to screening~* significant hypertension~* subjects with a history or clinical suspicion of cerebral vascular malformations, transient ischaemic attack, or stroke~* bleeding disorders~* women known to be pregnant, who have given birth within the past 90 days, or who are breastfeeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 79 Years
- Healthy Volunteers: f

Study Arms:
- clopidogrel 600 mg (Type: ACTIVE_COMPARATOR): None
- prasugrel 60 mg (Type: ACTIVE_COMPARATOR): None
- prasugrel 30 mg (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).